Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eugene Braunwald, MD
TIMI Study Group, Boston, MA
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigative Site
Investigative Site, Belgium
- Investigative Site
Investigative Site, Canada
- Investigative Site
Investigative Site, Czechia
- Investigative Site
Investigative Site, Germany
- Investigative Site
Investigative Site, Hungary
- Investigative Site
Investigative Site, Netherlands
- Investigative Site
Investigative Site, Poland
- Investigative Site
Investigative Site, Russia
- Investigative Site
Investigative Site, Spain
- Investigative Site
Investigative Site, Sweden
- Investigative Site
Investigative Site, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2007
- Primary completion
- 30 Apr 2009
- Completion
- 30 Apr 2009
- Last update posted
- 19 Apr 2011
- Registered enrollment
- 1,101
- Registry id
- NCT00409578
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.